<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="185151">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00683644</url>
  </required_header>
  <id_info>
    <org_study_id>TRI Grant RT 06 10</org_study_id>
    <nct_id>NCT00683644</nct_id>
  </id_info>
  <brief_title>Zinc to Treat Tinnitus</brief_title>
  <official_title>Zinc to Treat Tinnitus in the Elderly</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Iowa</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Tinnitus Research Initiative</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Iowa</source>
  <brief_summary>
    <textblock>
      There is widespread belief and some evidence to indicate that zinc can successfully treat
      tinnitus. Zinc deficiency is more likely to occur in the elderly . The primary objective of
      this study is to establish the effectiveness of zinc for the treatment of tinnitus in
      individuals 60 years of age and older. Subjects will be randomly assigned to either receive
      zinc daily or a placebo. After 4 months and a 1-month wash-out, the subjects will be crossed
      over to the other group.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2008</start_date>
  <completion_date type="Anticipated">December 2009</completion_date>
  <primary_completion_date type="Anticipated">December 2009</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double Blind (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Tinnitus loudness and annoyance</measure>
    <time_frame>10 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Tinnitus handicap</measure>
    <time_frame>10 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Tinnitus</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Zinc first, then placebo</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Placebo first, then zinc</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Zinc sulfate</intervention_name>
    <description>Zinc sulfate taken once daily</description>
    <arm_group_label>1</arm_group_label>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  60 years of age or older

          -  Tinnitus for 6 months or more

          -  Normal copper levels

          -  Be generally healthy

        Exclusion Criteria:

          -  Have a treatable otological disorder

          -  Involved in litigation

          -  Have or are suspected of having a serious psychiatric problem

          -  Involved in other treatments for tinnitus

          -  Are taking drugs which might interact with zinc and result in tinnitus

          -  Have copper deficiency

          -  Have Zinc levels above normal

          -  Are cognitively impaired.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Richard S. Tyler, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Iowa</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Anne Gehringer</last_name>
    <phone>319-353-8760</phone>
  </overall_contact>
  <location>
    <facility>
      <name>University of Iowa</name>
      <address>
        <city>Iowa City</city>
        <state>Iowa</state>
        <zip>52242</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Richard S. Tyler, Ph.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2009</verification_date>
  <lastchanged_date>February 13, 2009</lastchanged_date>
  <firstreceived_date>May 21, 2008</firstreceived_date>
  <responsible_party>
    <name_title>Richard S. Tyler, Ph.D.</name_title>
    <organization>University of Iowa</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Tinnitus</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Zinc</mesh_term>
    <mesh_term>Zinc Sulfate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
